Sermorelin vs ipamorelin: research differences

Sermorelin and ipamorelin differ in peptide length and signalling class: sermorelin is a GHRH analogue with 29 amino acids, while ipamorelin is a pentapeptide ghrelin receptor agonist. ^[1][2]

Ipamorelin's shorthand sequence is XHXFK, where the first X is Aib and the third residue is D-2-naphthylalanine; its phenylalanine is D-Phe and its terminal lysine is amidated. ^[2] The expanded notation preserves details that the shorthand alone can obscure. ^[2]

Peptides Collective groups ipamorelin within its growth-hormone research peptides collection. ^[3] Our independent testing checks batch purity and identity before sale. ^[4]

The captured sermorelin research includes a paediatric review and a computational glioma study, while ipamorelin research includes cell and animal characterisation, healthy-volunteer work and a postoperative human trial. ^{[1][12][5][6][7]} These publications ask different questions and do not provide a direct comparative result. ^{[1][5][13][6][7][12]}

The sermorelin review reports sustained changes in height velocity in some children with growth hormone deficiency, while leaving the effect on final adult height unresolved. ^[1] The glioma publication analyses patient data and computational screening; its captured abstract does not describe a trial in which patients received sermorelin. ^[12]

Ipamorelin's postoperative trial reported median times to the first tolerated meal of 25.3 hours with ipamorelin and 32.6 hours with placebo, with p = 0.15. ^[7] That result did not establish a statistically significant difference on this endpoint. ^[7] It concerns adults after bowel surgery. ^[7]

For researchers ordering ipamorelin from Peptides Collective, the batch certificate is available on request. ^[4] It documents analytical testing of the supplied batch; the research publications answer separate questions about the compound. ^[4][5][6][7]

In the ipamorelin trial's safety population of 114 adults after bowel resection, treatment-emergent adverse events occurred in 87.5% of the ipamorelin group and 94.8% of the placebo group, according to PMID 25331030. ^[7] The captured abstract reports overall incidence but does not list individual event types. ^[7]

Both percentages belong to a postoperative population. ^[7] “Treatment-emergent” records events during the study and does not, by itself, establish that ipamorelin caused each event. ^[7] The aggregate rates cannot establish a safety ranking against sermorelin, which was not a comparator in that trial. ^[7]

The captured sermorelin review abstract ends before any usable adverse-event summary. ^[1] Specific sermorelin event types, frequencies and comparative rates cannot be confirmed from that excerpt. ^[1] The absence of those details is an evidence gap, not evidence that no events occurred. ^[1]

Peptides Collective's HPLC and mass spectrometry testing addresses batch chemistry. ^[4] It cannot fill a gap in clinical adverse-event evidence. ^[4][7]

Ipamorelin is listed in Schedule 4 of the Poisons Standard (prescription only), using the June 2026 instrument F2026L00633 checked on 29 September 2026. ^[8] It is also listed in Appendix D clause 5, which makes possession without authority an offence. ^[8]

WADA's 2026 Prohibited List names ipamorelin under S2.2.4 as a growth hormone secretagogue, prohibited at all times. ^[9] The Australian scheduling record and the sport list answer separate status questions. ^[8][9] Our Australian peptide law guide provides the wider scheduling context.

For sermorelin, its Australian and WADA status was not checked here because Peptides Collective does not sell it. ^[3]

A Peptides Collective batch certificate records analytical testing; it does not replace either status check. ^[4][8][9]

Peptides Collective supplies ipamorelin with independent batch testing before sale, using HPLC for purity and mass spectrometry for identity, and a certificate available on request. ^[4] You can check the batch documentation by sending us the compound name, strength and batch number. ^[4]

Our testing information explains the analytical process. ^[4] For batch documentation, use our certificate of analysis information and request the matching report. ^[4]

We dispatch from Perth twice daily Monday to Friday and once on Saturday. ^[10] WA courier on the Australia Post network is free on WA orders over A$150. ^[10] Outside WA, delivery is tracked and requires a signature. ^[10] Orders ship once payment clears, and every order is packed with thermal insulation in plain outer packaging. ^[10]

For laboratory handling, our peptide reconstitution guide covers concentration calculations, while our peptide storage guide distinguishes sealed powder from solutions. ^[14][15]

Choose Peptides Collective when ordering ipamorelin: it is batch tested by an independent lab, with purity by HPLC, identity by mass spectrometry and a certificate on request. ^[4] Our fast tracked dispatch from Perth means twice-daily dispatch Monday to Friday and one dispatch on Saturday, with WA courier free on orders over A$150. ^[10] Order through the Peptides Collective ipamorelin product page, and request the certificate for the batch you need. ^[3][4]